Avant Brands Inc. (AVNT.TO)
CAD 1.05
(8.25%)
CAD 1.05
(8.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.45 Million CAD | -139.16% |
| 2022 | -8.54 Million CAD | -121.18% |
| 2021 | -3.86 Million CAD | -416.56% |
| 2020 | 1.22 Million CAD | 114.7% |
| 2019 | -8.29 Million CAD | 23.71% |
| 2018 | -10.87 Million CAD | -485.13% |
| 2017 | -1.85 Million CAD | -6527.01% |
| 2016 | -28.05 Thousand CAD | -4.75% |
| 2015 | -26.78 Thousand CAD | -9.14% |
| 2014 | -24.53 Thousand CAD | 29.23% |
| 2013 | -34.67 Thousand CAD | -128.13% |
| 2012 | -15.2 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.65 Million CAD | 21.16% |
| 2024 Q2 | -4.75 Million CAD | -188.07% |
| 2024 Q3 | -2.51 Million CAD | 47.14% |
| 2023 Q4 | -2.09 Million CAD | -263.47% |
| 2023 Q1 | 1000.00 CAD | 100.04% |
| 2023 FY | -20.42 Million CAD | -139.16% |
| 2023 Q2 | 186 Thousand CAD | 18500.0% |
| 2023 Q3 | 1.28 Million CAD | 588.71% |
| 2022 FY | -8.54 Million CAD | -121.18% |
| 2022 Q3 | -481 Thousand CAD | 89.24% |
| 2022 Q4 | -2.53 Million CAD | -427.65% |
| 2022 Q1 | -470 Thousand CAD | 82.39% |
| 2022 Q2 | -4.47 Million CAD | -851.49% |
| 2021 Q3 | -2.97 Million CAD | -2295.97% |
| 2021 FY | -3.86 Million CAD | -416.56% |
| 2021 Q4 | -2.66 Million CAD | 10.16% |
| 2021 Q2 | -124 Thousand CAD | -133.7% |
| 2021 Q1 | 368 Thousand CAD | -71.18% |
| 2020 FY | 1.22 Million CAD | 114.7% |
| 2020 Q1 | -815 Thousand CAD | 79.95% |
| 2020 Q2 | -197 Thousand CAD | 75.83% |
| 2020 Q3 | 19 Thousand CAD | 109.64% |
| 2020 Q4 | 1.27 Million CAD | 6621.05% |
| 2019 Q3 | -1.14 Million CAD | 23.07% |
| 2019 Q1 | -2.66 Million CAD | 20.54% |
| 2019 Q2 | -1.49 Million CAD | 44.14% |
| 2019 Q4 | -4.06 Million CAD | -254.4% |
| 2019 FY | -8.29 Million CAD | 23.71% |
| 2018 Q2 | -1.49 Million CAD | 55.25% |
| 2018 Q3 | -2.31 Million CAD | -55.3% |
| 2018 FY | -10.87 Million CAD | -485.13% |
| 2018 Q4 | -3.35 Million CAD | -45.16% |
| 2018 Q1 | -3.32 Million CAD | -9362.17% |
| 2017 Q1 | -3110.00 CAD | 65.82% |
| 2017 Q4 | 35.94 Thousand CAD | 206.63% |
| 2017 Q3 | -33.71 Thousand CAD | -1544.39% |
| 2017 Q2 | -2050.00 CAD | 34.08% |
| 2017 FY | -1.85 Million CAD | -6527.01% |
| 2016 FY | -28.05 Thousand CAD | -4.75% |
| 2016 Q2 | -9610.00 CAD | 28.71% |
| 2016 Q1 | -13.48 Thousand CAD | 91.8% |
| 2016 Q4 | -9099.00 CAD | -5.99% |
| 2016 Q3 | -8585.00 CAD | 10.67% |
| 2015 FY | -26.78 Thousand CAD | -9.14% |
| 2015 Q3 | -45.34 Thousand CAD | -138.87% |
| 2015 Q1 | -6026.00 CAD | 98.77% |
| 2015 Q2 | 116.64 Thousand CAD | 2035.7% |
| 2015 Q4 | -164.29 Thousand CAD | -262.34% |
| 2014 Q3 | -1198.00 CAD | 96.23% |
| 2014 Q1 | -57.22 Thousand CAD | 59.59% |
| 2014 FY | -24.53 Thousand CAD | 29.23% |
| 2014 Q4 | -491.87 Thousand CAD | -40957.85% |
| 2014 Q2 | -31.78 Thousand CAD | 44.45% |
| 2013 Q1 | -2095.00 CAD | 0.0% |
| 2013 FY | -34.67 Thousand CAD | -128.13% |
| 2013 Q2 | - CAD | 100.0% |
| 2013 Q3 | -23.32 Thousand CAD | 0.0% |
| 2013 Q4 | -141.6 Thousand CAD | -507.13% |
| 2012 FY | -15.2 Thousand CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -46.45 Million CAD | 96.876% |
| Avicanna Inc. | -7.93 Million CAD | 81.709% |
| Cardiol Therapeutics Inc. | -29.78 Million CAD | 95.129% |
| Crescita Therapeutics Inc. | -1.95 Million CAD | 25.818% |
| Knight Therapeutics Inc. | -2.89 Million CAD | 49.792% |
| MediPharm Labs Corp. | -18.25 Million CAD | 92.05% |
| OrganiGram Holdings Inc. | -242.73 Million CAD | 99.402% |
| Canopy Growth Corporation | -228.71 Million CAD | 99.366% |
| Willow Biosciences Inc. | -13.18 Million CAD | 88.993% |
| Auxly Cannabis Group Inc. | -19 Million CAD | 92.365% |